title: Effects of formulation variables and post-compression curing on drug release from a new sustained-release matrix material: polyvinylacetate-povidone.
abstract: A new commercially available sustained-release matrix material, Kollidon SR, composed of polyvinylacetate and povidone, was evaluated with respect to its ability to modulate the in vitro release of a highly water-soluble model compound, diphenhydramine HCl. Kollidon SR was found to provide a sustained-release effect for the model compound, with certain formulation and processing variables playing an important role in controlling its release kinetics. Formulation variables affecting the release include the level of the polymeric material in the matrix, excipient level, as well as the nature of the excipients (water soluble vs. water insoluble). Increasing the ratio of a water-insoluble excipient, Emcompress, to Kollidon SR enhanced drug release. The incorporation of a water-soluble excipient, lactose, accelerated its release rate in a more pronounced manner. Stability studies conducted at 40 degrees C/75% RH revealed a slow-down in dissolution rate for the drug-Kollidon SR formulation, as a result of polyvinylacetate relaxation. Further studies demonstrated that a post-compression curing step effectively stabilized the release pattern of formulations containing > or = 47% Kollidon SR. The release mechanism of Kollidon-drug and drug-Kollidon-Emcompress formulations appears to be diffusion controlled, while that of the drug-Kollidon-lactose formulation appears to be controlled predominantly by diffusion along with erosion.
authors: Formulation R&D, Pfizer Global Research and Development, 170 Tabor Road, Morris Plains, NJ 07950, USA. z.jesse.shao@pfizer.com
authors: Z J
authors: ZJ
authors: Shao
authors: M I
authors: MI
authors: Farooqi
authors: S
authors: S
authors: Diaz
authors: A K
authors: AK
authors: Krishna
authors: N A
authors: NA
authors: Muhammad
mesh_terms: D002626:Chemistry, Pharmaceutical; D003692:Delayed-Action Preparations; D004155:Diphenhydramine / Q000008:administration & dosage*; D011145:Polyvinyls / Q000008:administration & dosage*; D011205:Povidone / Q000008:administration & dosage*; D012995:Solubility; D013607:Tablets
chemical_list: D003692:Delayed-Action Preparations; D011145:Polyvinyls; D013607:Tablets; C013215:polyvinyl acetate; D004155:Diphenhydramine; D011205:Povidone